Laurion Capital Management LP Coherus Bio Sciences, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $234,757 - $568,437	147,646 New	147,646 $491,000
Q3 2018 Nov 13, 2018	SELL	$14.45 - $20.25 $1.82 Million - $2.56 Million	-126,201 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$10.25 - $17.45 $896,065 - $1.53 Million	87,421 Added 225.43%	126,201 $1.77 Million
Q1 2018 May 14, 2018	BUY	$9.1 - $13.7 $352,898 - $531,286	38,780 New	38,780 $428,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.